drugset / Trial / NCT00214864
A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to attempt to find better tolerated doses and schedules of this highly effective combination chemotherapy regimen.
Timeline
- Start
- 2002-12
- Primary completion
- 2006-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 650 mg/m2 | Oral |
| Subject | Capecitabine | Small molecule | 850 mg/m2 | Oral |
| Subject | Capecitabine | Small molecule | 900 mg/m2 | Oral |
| Subject | Docetaxel | Small molecule | 30 mg/m2 | — |
| Subject | Docetaxel | Small molecule | 36 mg/m2 | — |